Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction.
Peng YuShuai SongXiaokai ZhangShujun CuiGang WeiZihang HuangLinqi ZengTing NiAi-Jun SunPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
Myocardial infarction (MI) is a leading cause of heart failure (HF), associated with morbidity and mortality worldwide. As an essential part of gene expression regulation, the role of alternative polyadenylation (APA) in post-MI HF remains elusive. Here, we revealed a global, APA-mediated, 3' untranslated region (3' UTR)-lengthening pattern in both human and murine post-MI HF samples. Furthermore, the 3' UTR of apoptotic repressor gene, AVEN , is lengthened after MI, contributing to its downregulation. AVEN knockdown increased cardiomyocyte apoptosis, whereas restoration of AVEN expression substantially improved cardiac function. Mechanistically, AVEN 3' UTR lengthening provides additional binding sites for miR-30b-5p and miR-30c-5p, thus reducing AVEN expression. Additionally, PABPN1 (poly(A)-binding protein 1) was identified as a potential regulator of AVEN 3' UTR lengthening after MI. Altogether, our findings revealed APA as a unique mechanism regulating cardiac injury in response to MI and also indicated that the APA-regulated gene, AVEN , holds great potential as a critical therapeutic target for treating post-MI HF.
Keyphrases
- heart failure
- binding protein
- gene expression
- cell death
- left ventricular
- cell proliferation
- acute heart failure
- poor prognosis
- endothelial cells
- genome wide
- oxidative stress
- copy number
- signaling pathway
- transcription factor
- long non coding rna
- single cell
- children with cerebral palsy
- dna methylation
- angiotensin ii
- cell cycle arrest
- climate change
- atrial fibrillation
- risk assessment
- muscular dystrophy
- human health
- high glucose
- pluripotent stem cells